1.
Wollenberg A, Guttman-Yassky E, Torpet M, Silverberg JI. Risk of anaphylaxis and conjunctivitis with tralokinumab in atopic dermatitis. J of Skin [Internet]. 2018Dec.17 [cited 2020Dec.3];20:S63. Available from: https://jofskin.org/index.php/skin/article/view/459